Scotia Capital’s Xylem XYL Stock Holding History

Scotia Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40,000	Closed	-$1.31M	–	837
2015 Q3	$1.31M	Buy	+40,000	New	+$1.35M	0.03%	333

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Scotia Capital's XYL Position: Q2 2026 in Review

Scotia Capital reduced its Xylem (XYL) stake by 5.1% in Q2 2026, selling an estimated $277K and leaving 44,333 shares worth $5.24M. The position accounts for 0.02% of the portfolio, ranked #311.

Scotia Capital first reported a position in XYL in Q3 2017 and has held it in 36 quarters since. The position peaked at $8.03M in Q1 2019. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Scotia Capital held 44,333 shares of Xylem worth $5.24M as of Q2 2026.
Scotia Capital sold 2,398 Xylem shares in Q2 2026, an estimated $277K.
Xylem made up 0.02% of Scotia Capital's portfolio in Q2 2026, its #311 holding.
Scotia Capital first reported a position in Xylem in Q3 2017 and has held it in 36 quarters since.
Scotia Capital's Xylem position peaked at $8.03M in Q1 2019.
1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.